Great Novel Therapeutics Biotech & Medicals (ROCO:7427) FFO


ROCO:7427 Great Novel Therapeutics Biotech & Medicals ROCO:7427
52 GF Score
Price NT$39.55
GF Value NT$25.62
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Great Novel Therapeutics Biotech & Medicals FFO?

FFO (Funds from operations) only applies to REITs.

ROCO:7427
52GF Score
Great Novel Therapeutics Biotech & Medicals ROCO:7427
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Overvalued in 2026?

Based on GuruFocus' analysis, Great Novel Therapeutics Biotech & Medicals stock appears to be overvalued. The current stock price of NT$39.55 is trading 54.4% above its estimated GF Value™ of NT$25.62. GuruFocus considers Great Novel Therapeutics Biotech & Medicals to be Significantly Overvalued.

Key valuation signals for ROCO:7427:

  • FFO:
  • GF Value™: NT$25.62 vs. price of NT$39.55 (54.4% above fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the ROCO:7427 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Great Novel Therapeutics Biotech & Medicals Business Description

Address No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503
Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.
52GF Score

Get the complete analysis for ROCO:7427

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$39.55
Price
NT$25.62
GF Value